Steris (STE) financial statements
+127.2%since 2017
- FY2026 revenue
- $5.9B▲ +8.7%
- FY2026 net income
- $782M▲ +27.3%
- FY2026 diluted EPS
- $7.93▲ +27.9%
- FY2026 free cash flow
- $972M▲ +25.0%
Steris income statement
| USD millions | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Period ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
| Revenue | 5,936 | 5,460 | 5,139 |
| Gross profit | 2,627 | 2,403 | 2,218 |
| Operating income | 1,102 | 867 | 836 |
| Pretax income | 1,047 | 796 | 703 |
| Net income | 782 | 615 | 378 |
| Diluted earnings per share | 7.93 | 6.20 | 3.81 |
Steris balance sheet
| USD millions | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Period ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
| Cash and cash equivalents (derived) | 440 | 172 | 207 |
| Total assets | 10,737 | 10,147 | 11,064 |
| Total liabilities | 3,540 | 3,531 | 4,748 |
| Total equity | 7,197 | 6,616 | 6,315 |
| Long-term debt | 1,813 | 1,919 | 3,120 |
Steris cash flow statement
| USD millions | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Period ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
| Operating cash flow | 1,341 | 1,148 | 973 |
| Capital expenditure | -369 | -370 | -360 |
| Free cash flow (derived) | 972 | 778 | 613 |
| Dividends paid | -242 | -220 | -201 |
| Share repurchases | -235 | -211 | -12 |
Quarterly highlights
| USD millions | Q2 FY2027 | Q1 FY2027 | Q4 FY2026 | Q3 FY2026 |
|---|---|---|---|---|
| Period ended | 30 Sep 2026 | 30 Jun 2026 | 31 Mar 2026 | 31 Dec 2025 |
| Revenue (derived) | 1,589 | 1,493 | 1,588 | 1,496 |
| Operating income (derived) | 294 | 286 | 317 | 273 |
| Net income (derived) | 214 | 200 | 220 | 193 |
| Diluted earnings per share | 2.19 | 2.04 | n/a | 1.96 |
| Operating cash flow (derived) | 289 | 367 | 335 | 298 |
| Total assets | 10,714 | 10,736 | 10,737 | 10,591 |
Steris major shareholders
| Holder | Share of class | Shares | Filed |
|---|---|---|---|
| Vanguard Capital Management | 7.5% | 7,340,236 | 30 April 2026 |
| STATE STREET CORPORATION | 5.1% | 4,995,259 | 12 May 2026 |
| Vanguard Portfolio Management | 5.1% | 4,962,018 | 29 April 2026 |
Steris 10-K and SEC filings
| Filed | Form | Type | Description |
|---|---|---|---|
| 12 November 2026 | 8-K | Current report | Current report |
| 5 November 2026 | 10-Q | Quarterly report | Quarterly report |
| 4 November 2026 | 8-K | Current report | Current report |
| 4 November 2026 | 8-K | Current report | Current report |
| 13 October 2026 | 8-K | Current report | Current report |
| 7 August 2026 | 10-Q | Quarterly report | Quarterly report |
| 6 August 2026 | 8-K | Current report | Current report |
| 5 August 2026 | 8-K | Current report | Current report |
Common questions
What was Steris' revenue in fiscal 2026?
Steris reported $5.9 billion in revenue for fiscal 2026, the year ended 31 March 2026, up 8.7% from fiscal 2025.
What was Steris' net income in fiscal 2026?
Steris reported net income of $782 million for fiscal 2026, the year ended 31 March 2026, up 27.3% from fiscal 2025. Diluted earnings per share were $7.93.
What was Steris' free cash flow in fiscal 2026?
Steris had $972 million in free cash flow in fiscal 2026. Operating cash flow was $1.3 billion and capital expenditure was $369 million.
What were Steris' total assets at the end of fiscal 2026?
Steris reported total assets of $10.7 billion at the end of fiscal 2026, the year ended 31 March 2026.
How much Steris history do I get?
Every account gets the full history, annual and quarterly, with first reported values and as of dates.
Start with a free key
Free $10 credits every month, no card.Free $10 credits a month, no card.